Chalmers, Katy A <br/><br/>
Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.  [electronic resource] 

 -  Journal of neuropathology and experimental neurology  Nov 2007 
 - 1019-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3069 
<br/><br/><label>Standard No.: </label>10.1097/nen.0b013e31815885ad  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Blotting, Western<br/>Brain--metabolism<br/>Female<br/>Fluorescent Antibody Technique<br/>Humans<br/>Immunohistochemistry<br/>Inclusion Bodies--metabolism<br/>Lewy Body Disease--metabolism<br/>Male<br/>Multiple System Atrophy--metabolism<br/>Neurodegenerative Diseases--metabolism<br/>Phosphorylation<br/>Pick Disease of the Brain--metabolism<br/>Protein Transport<br/>Smad Proteins--metabolism<br/>Supranuclear Palsy, Progressive--metabolism<br/>alpha-Synuclein--metabolism<br/>tau Proteins--metabolism